The Stock Market Just Finished Its Best Quarter in Years. Here's What History Says Is Coming Next.

S&P 500 is up nearly 15% in Q2 2026 and roughly 10% in the first half, putting it on pace for a fourth consecutive year of double-digit gains. The article cites FactSet expectations of 24% earnings growth in 2026 and 17% in 2027, suggesting earnings can support further upside despite risks from high inflation and potential Fed rate hikes. Valuation is framed as reasonable (forward P/E ~23), with skepticism tied to elevated Shiller CAPE near an all-time high.

Analysis

Near term, the market’s support is less about macro optimism than about earnings concentration: a handful of large-cap growth names can keep the index levitating even if the median stock is flat. That favors cap-weighted exposure like VOO/SPY over equal-weight, and it keeps the AI supply chain — especially NVDA and select semiconductor equipment names — as the cleanest beneficiary of still-elevated capex budgets.

The main risk is a rates shock rather than a growth shock. If inflation re-accelerates or the Fed turns more hawkish, long-duration multiples compress first, and that pressure would likely show up in QQQ, semis, and small caps before it hits the broader index. The key catalyst path over 1-3 months is CPI/Fed and forward EPS revisions; if those roll over while the 10Y backs up, this becomes a de-risking event, not just a style rotation.

Contrarian take: the consensus is reading index strength as broad health, but the better read is fragile breadth with a very narrow leadership base. That is constructive for passive cap-weighted owners in the 6-18 month window, but it is not a blanket ‘buy everything’ tape. If breadth improves and cyclicals finally participate, the current concentration premium in mega-cap growth will fade; if not, the market can grind higher while most names underperform.

Key Decisions for Investors

• Long NVDA vs. short IWM for 1-3 months: express the view that AI earnings/capex outpace rate-sensitive small caps; target relative outperformance into next earnings season, invalidate if small caps begin sustaining leadership on falling yields.
• Add to SPY/VOO on 2-3% pullbacks rather than chasing strength: cap-weighted exposure should keep benefiting from earnings concentration; risk/reward worsens if forward EPS revisions flatten.
• Underweight RSP vs. SPY: if leadership remains narrow, equal-weight should lag as the biggest contributors keep compounding; cover if market breadth materially improves and cyclicals start beating on rising participation.
• Use NVDA as the cleanest upside beta to the earnings-driven bull case, but pair with a macro hedge (e.g., short TLT or reduce duration exposure) if the 10Y yield breaks higher; thesis fails if yields rise without offsetting EPS upgrades.